León-Castillo, A., de Boer, S. M., Powell, M. E., Mileshkin, L. R., Mackay, H. J., Leary, A., . . . Bosse, T. (2020). Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy. J Clin Oncol.
Chicago-stil citatLeón-Castillo, Alicia, et al. "Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact On Prognosis and Benefit From Adjuvant Therapy." J Clin Oncol 2020.
MLA-referensLeón-Castillo, Alicia, et al. "Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact On Prognosis and Benefit From Adjuvant Therapy." J Clin Oncol 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.